CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 89 filers reported holding CARDIFF ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 2.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $51 | -5.6% | 36,500 | 0.0% | 0.00% | – |
Q2 2023 | $54 | -11.5% | 36,500 | 0.0% | 0.00% | – |
Q1 2023 | $61 | +19.6% | 36,500 | 0.0% | 0.00% | – |
Q4 2022 | $51 | -99.9% | 36,500 | 0.0% | 0.00% | – |
Q3 2022 | $57,000 | -28.8% | 36,500 | 0.0% | 0.00% | – |
Q2 2022 | $80,000 | +50.9% | 36,500 | +69.9% | 0.00% | – |
Q1 2022 | $53,000 | -57.3% | 21,480 | +3.9% | 0.00% | – |
Q4 2021 | $124,000 | -98.7% | 20,680 | -96.1% | 0.00% | -100.0% |
Q4 2020 | $9,528,000 | +21.3% | 529,627 | -4.3% | 0.00% | 0.0% |
Q3 2020 | $7,852,000 | – | 553,359 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |